{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:30:19Z","timestamp":1789813819384,"version":"4.0.1"},"reference-count":0,"publisher":"Informa UK Limited","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s3169","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T21:48:04Z","timestamp":1284414484000},"page":"27","source":"Crossref","is-referenced-by-count":6,"title":["Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases"],"prefix":"10.2147","author":[{"given":"Thomas","family":"Polascik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2008,12]]},"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=4105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T21:57:32Z","timestamp":1477864652000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/bisphosphonates-in-oncology-evidence-for-the-prevention-of-skeletal-ev-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/dddt.s3169","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}